Flemington, NJ, United States of America

Mahesh N Samtani

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Janssen Pharmaceuticals, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mahesh N Samtani. Retrieved from https://idiyas.com/inventor/mahesh-n-samtani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 17.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mahesh N Samtani: Innovator in Pharmaceutical Compositions

Introduction

Mahesh N Samtani is a notable inventor based in Flemington, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative compositions. His work focuses on enhancing the efficacy of medications, which can have a profound impact on patient care.

Latest Patents

Mahesh N Samtani holds 1 patent for his invention titled "Compositions comprising aticaprant." This patent relates to compositions, including oral formulations in the form of tablets, that incorporate aticaprant and outlines methods for their use. This innovation is crucial for developing effective treatments in the pharmaceutical industry.

Career Highlights

Currently, Mahesh N Samtani is employed at Janssen Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His role at this prominent company allows him to collaborate with other experts in the field and contribute to groundbreaking pharmaceutical solutions.

Collaborations

Some of his notable coworkers include Nicolaas Martha Felix Goyvaerts and Mark Schmidt. Their collective expertise fosters a collaborative environment that enhances the innovation process within the company.

Conclusion

Mahesh N Samtani exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly through his patent on aticaprant compositions, highlight the importance of research and development in creating effective medical solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…